Topical Treatment of Pyoderma gangraenosum
- 1 July 2002
- journal article
- editorial
- Published by S. Karger AG in Dermatology
- Vol. 205 (3) , 221-223
- https://doi.org/10.1159/000065843
Abstract
The treatment of pyoderma gangraenosum (PG) is still a therapeutic challenge. Although several drugs such as corticosteroids, dapsone, clofazimine, azathioprine, tacrolimus and cyclosporine A have been shown to be effective in this disease, side-effects of these agents limit their systemic use in seriously ill patients. In recent years, topical treatment of the disease has gained attention. Several reports show an improvement of cutaneous lesions of PG following topical treatment. These earlier reports as well as our own observations suggest that topical therapeutic regimens can be a useful and safe alternative to systemic immunosuppressive therapy in the treatment of PG. We give a review about these topically used drugs and the mechanisms probably involved.Keywords
This publication has 4 references indexed in Scilit:
- Recalcitrant pyoderma gangrenosum treated with systemic tacrolimusBritish Journal of Dermatology, 1999
- Topical tacrolimus for pyoderma gangrenosumBritish Journal of Dermatology, 1998
- Erfolgreiche topische Anwendung von Cyclosporin A bei Pyoderma gangraenosumDie Dermatologie, 1996
- "Pyoderma (ecthyma) gangrenosum" by Brunsting, Goeckerman and O'Leary, October 1930. Commentary: Pyoderma gangrenosumArchives of Dermatology, 1982